Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CHGB | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | MRPS36 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ARRDC2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PCDHA11 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | EOGT | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CCDC81 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | RAB40A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CTD-2313N18.7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PPP1R2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ACP6 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |